“”It is possible to reach levels of efficiency similar to those of female contraceptives with prolonged action, such as IUD“, Assures Kevin Eisenfrats, co -founder and CEO of contractin, about what could be a revolution in the field of contraception. Adam is a hydrogel injected into the defending channel (which allows sperm to get out of the testicles) and which blocks their passage while allowing ejaculation, explains the American online magazine Gizmodo. Surgical injected by a professional, this product is still today in the test phase.
Australian doctors applied freezing in twenty-three adults aged 25 to 65. Currently, published trials focus on the effectiveness of the technique, but it is too early to know if fertility can be restored after the dissolution or withdrawal of hydrogel. Jon Oatley, professor at the Washington University of Molecular Bioscience School, underlined to the British daily The Guardian that there is not yet data confirming the reversibility of injection.
Men prefer patches
The results of the latest tests led by the Charlottesville contract-up-up-up in Virginia state, are promising. After twenty-four months of follow-up, patients still had azoospermia (absence of sperm in the ejaculate). This method would allow a 100% reduction in the number of sperm in just thirty days, a major innovation.
According to the company, no participant has presented serious adverse effects. The researchers therefore decided to extend their clinical trials to a larger number of patients, by ensuring regular monitoring. If the Adam contraception method turns out to be reliable, it could become a poorly invasive and effective male contraception.
Among women, the pill has been dethroned for a few years dethroned by long -term methods such as the implant or the IUD. In men, the most common methods remain condom and vasectomy. Jon Oatley recalls, however, that most men would prefer to have a pill or put a patch rather than submit to surgery.
Not won for the injection of hydrogel which still requires many tests, on a larger panel of patients and over a longer time. The marketing stage is still far away.
